New Drugs for InsomniaComparative Tolerability of Zopiclone, Zolpidem and Zaleplon

被引：0
|
作者：
Mario Giovanni Terzano
Mariano Rossi
Vincenzo Palomba
Arianna Smerieri
Liborio Parrino
机构：
[1] Sleep Disorders Center,
[2] University of Parma,undefined
[3] Istituto di Neurologia - Università,undefined
来源：
Drug Safety | 2003年 / 26卷
关键词：
Zolpidem; Triazolam; Zopiclone; Flunitrazepam; Zaleplon;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Insomnia affects 30–35% of people living in developed countries. The impact of insomnia on daytime functioning and its relationship with medical and psychiatric illnesses necessitate early treatment to prevent insomnia becoming persistent and to avoid the development of complications. However, pharmacological strategies must achieve a balance between sedative and adverse effects.
引用
收藏
页码：261 / 282
页数：21
相关论文
共 50 条
12345